Global Cardiopulmonary Auto-transfusion System Market Growth 2023-2029

Global Cardiopulmonary Auto-transfusion System Market Growth 2023-2029

Cardiopulmonary auto-transfusion system is a device that provides autologous blood during surgical procedures.

LPI (LP Information)' newest research report, the “Cardiopulmonary Auto-transfusion System Industry Forecast” looks at past sales and reviews total world Cardiopulmonary Auto-transfusion System sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiopulmonary Auto-transfusion System sales for 2023 through 2029. With Cardiopulmonary Auto-transfusion System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiopulmonary Auto-transfusion System industry.

This Insight Report provides a comprehensive analysis of the global Cardiopulmonary Auto-transfusion System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiopulmonary Auto-transfusion System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiopulmonary Auto-transfusion System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiopulmonary Auto-transfusion System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiopulmonary Auto-transfusion System.

The global Cardiopulmonary Auto-transfusion System market size is projected to grow from US$ 514.1 million in 2022 to US$ 589.4 million in 2029; it is expected to grow at a CAGR of 589.4 from 2023 to 2029.

After observing the negative effects of using allogenic blood transfusions, surgeons gradually adopt the auto-transfusion system in a bid to eliminate complications and the spread of diseases through cardiac surgeries.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Auto-transfusion System market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
On-Pump Transfusion Device
Off-Pump Transfusion Device

Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Haemonetics
Medtronic
LivaNova
Fresenius
Terumo Interventional Systems
Wandong Health Sources

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiopulmonary Auto-transfusion System market?

What factors are driving Cardiopulmonary Auto-transfusion System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiopulmonary Auto-transfusion System market opportunities vary by end market size?

How does Cardiopulmonary Auto-transfusion System break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.